Columbia Wanger Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$27.9M Buy
2,267,357
+53,298
+2% +$751K 0.42% 110
2017
Q3
$39.4M Buy
2,214,059
+218,002
+11% +$4.49M 0.58% 69
2017
Q2
$50.6M Buy
1,996,057
+1,504,696
+306% +$36.2M 0.72% 49
2017
Q1
$11M Buy
491,361
+31,313
+7% +$601K 0.15% 174
2016
Q4
$6.81M Buy
+460,048
New +$9.06M 0.1% 191

Other funds holding EVH

Columbia Wanger Asset Management's EVH Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Evolent Health (EVH) stake by 2.4% in Q4 2017, buying an estimated $751K and bringing the position to 2,267,357 shares worth $27.9M. The position accounts for 0.42% of the portfolio, ranked #110.

Columbia Wanger Asset Management first reported a position in EVH in Q4 2016 and has held it in 5 quarters since. The position peaked at $50.6M in Q2 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • Columbia Wanger Asset Management held 2,267,357 shares of Evolent Health worth $27.9M as of Q4 2017.
  • Columbia Wanger Asset Management bought 53,298 Evolent Health shares in Q4 2017, an estimated $751K.
  • Evolent Health made up 0.42% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #110 holding.
  • Columbia Wanger Asset Management first reported a position in Evolent Health in Q4 2016 and has held it in 5 quarters since.
  • Columbia Wanger Asset Management's Evolent Health position peaked at $50.6M in Q2 2017.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.